In particular, in hypertensive subjects aged 60 years or older, AF prevalence was highest in SEPHAR IV (16.3% ( n = 63)) compared to SEPHAR III (13.1% ( n = 55) and SEPHAR II (12% ( n = 41); however, it did not reach statistical significance ( p = 0.211).
← all excerpts
Nine-Year Trends in Atrial Fibrillation Prevalence among Romanian Adult Hypertensives: A Post-Hoc Analysis of SEPHAR II-IV Surveys.
1
0.2110
0.2110